1. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010; 62:177–188.
2. Tosti A, Bellavista S, Iorizzo M. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol. 2006; 55:438–441.
Article
3. Tan E, Tay YK, Giam YC. A clinical study of childhood alopecia areata in Singapore. Pediatr Dermatol. 2002; 19:298–301.
Article
4. Xiao FL, Yang S, Liu JB, He PP, Yang J, Cui Y, et al. The epidemiology of childhood alopecia areata in China: a study of 226 patients. Pediatr Dermatol. 2006; 23:13–18.
Article
5. Walker SA, Rothman S. A statistical study and consideration of endocrine influences. J Invest Dermatol. 1950; 14:403–413.
6. Jang YH, Hong NS, Moon SY, Eun DH, Lee WK, Chi SG, et al. Long-term prognosis of alopecia totalis and alopecia universalis: a longitudinal study with more than 10 years of follow-up: better than reported. Dermatology. 2017; 233:250–256.
Article
7. Lee JC, Kim HY, Kim HJ, Kim BS, Lee WJ, Lee SJ, et al. Long term follow-up study of corticosteroid-treated patients with alopecia areata. Korean J Dermatol. 2008; 46:465–472.
8. Otberg N, Shapiro J. Hair growth disorders. In : Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill;2012. p. 993.
9. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG. British Association of Dermatologists. Guidelines for the management of alopecia areata. Br J Dermatol. 2003; 149:692–699.
Article
10. Jang YH, Moon SY, Lee WJ, Lee SJ, Lee WK, Park BC, et al. Alopecia areata progression index, a scoring system for evaluating overall hair loss activity in alopecia areata patients with pigmented hair: a development and reliability assessment. Dermatology. 2016; 232:143–149.
Article